Lexaria has repeatedly evidenced higher brain levels upon gross necropsy in rodent studies with other DehydraTECH-processed active ingredients in the past that demonstrated superior safety and efficacy over controls, said John Docherty, Lexaria President and CSO
Ask Chicago's Expert
The vial is at its cleanest and most protected
Seven additional phase 3 readouts are expected throughout this year, covering a range of conditions including type 2 diabetes, obstructive sleep apnea, chronic low back pain, cardiovascular outcomes, and metabolic dysfunction-associated steatotic liver disease
Posttranslational modifications (PTMs), including phosphorylation, acetylation, methylation, and ubiquitination, play key roles in the regulation of p53